{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:11:31Z","timestamp":1794366691179,"version":"4.9.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Surgery"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ijsu.2022.106621","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T01:36:03Z","timestamp":1651109763000},"page":"106621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Impact of low-molecular-weight heparin in the treatment of moderately severe and severe acute pancreatitis; a randomized, single blind, phase 3 control trial"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3032-4343","authenticated-orcid":false,"given":"Basavaraj","family":"Patil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6993-6040","authenticated-orcid":false,"given":"Laxmi Narayan","family":"Meena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh Chandra","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogendra","family":"Dadhich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.ijsu.2022.106621_bib1","series-title":"Bailey & Love's Short Practice of Surgery","author":"Williams","year":"2018"},{"key":"10.1016\/j.ijsu.2022.106621_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5152\/tjg.2018.18583","article-title":"Low molecular weight heparin treatment of acute moderate and severe pancreatitis: a randomized, controlled, open-label study","volume":"30","author":"Tozlu","year":"2019","journal-title":"Turk. J. Gastroenterol."},{"key":"10.1016\/j.ijsu.2022.106621_bib4","series-title":"Sabiston Textbook of Surgery","author":"Coutney","year":"2019"},{"key":"10.1016\/j.ijsu.2022.106621_bib5","series-title":"Srb's Manual of Surgery","author":"Sriram Bhat","year":"2019"},{"key":"10.1016\/j.ijsu.2022.106621_bib6","article-title":"Anti-inflammatory effects of heparin and its derivatives: a systematic review","volume":"2015","author":"Mousavi","year":"2015","journal-title":"Adv Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.ijsu.2022.106621_bib7","article-title":"Inhibition of trypsin by heparin and dalteparin, a low molecular weight heparin","volume":"74","author":"Olivera","year":"2008","journal-title":"J. Serb. Chem. Soc."},{"key":"10.1016\/j.ijsu.2022.106621_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ijsu.2022.106621_bib9","series-title":"Schwartz's Principles of Surgery","author":"Brunicardi","year":"2019"},{"key":"10.1016\/j.ijsu.2022.106621_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chron. Dis."},{"key":"10.1016\/j.ijsu.2022.106621_bib11","series-title":"Introduction to Biostatistics and Research Methods","author":"Rao","year":"2012"},{"key":"10.1016\/j.ijsu.2022.106621_bib12","first-page":"500","article-title":"Low molecular weight heparin in the treatment of severe acute pancreatitis: a multiple center prospective clinical study","volume":"21","author":"Xin-Sheng","year":"2006","journal-title":"Chin. J. Gen. Surg."},{"issue":"8","key":"10.1016\/j.ijsu.2022.106621_bib13","article-title":"Clinical effects of low-molecular-weight heparin combined with ulinastatin in children with acute pancreatitis","volume":"15","author":"Ai-Hua","year":"2016","journal-title":"Trop. J. Pharmaceut. Res."},{"key":"10.1016\/j.ijsu.2022.106621_bib14","article-title":"Treatment of severe acute pancreatitis","volume":"8","author":"Du","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ijsu.2022.106621_bib15","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1172\/JCI1509","article-title":"Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents","volume":"101","author":"Koenig","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijsu.2022.106621_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/gut.47.1.14","article-title":"Heparin and inflammation: a new use for an old GAG?","volume":"47","author":"Perretti","year":"2000","journal-title":"Gut"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919122003983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919122003983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T16:08:24Z","timestamp":1677082104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1743919122003983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":15,"alternative-id":["S1743919122003983"],"URL":"https:\/\/doi.org\/10.1016\/j.ijsu.2022.106621","relation":{},"ISSN":["1743-9191"],"issn-type":[{"value":"1743-9191","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of low-molecular-weight heparin in the treatment of moderately severe and severe acute pancreatitis; a randomized, single blind, phase 3 control trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijsu.2022.106621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106621"}}